Skip to main content
SpringerLink
Log in

Liver Metastases from Ovarian and Uterus Cancer

  • Chapter
  • First Online:
Noncolorectal, Nonneuroendocrine Liver Metastases

  • 961 Accesses

Abstract

Liver metastases can be seen in all advanced gynecological cancers; however, the role of resection for these malignancies is not clearly defined. With the success of liver resection in the context of colorectal liver metastases, renewed interest in liver resection for other solid organ metastases has developed. In this chapter we explore the role of liver resection as part of cytoreduction for gynecological malignancy comparing and contrasting the patterns of disease. There does appear to be a role for resection of liver metastases in a carefully chosen population of patients. Generally the mortality and morbidity of resection is low and can provide improved survival rates if reserved for selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brunschwig A (1963) Hepatic lobectomy for metastatic cancer. Cancer 16:277–282

    Article  CAS  PubMed  Google Scholar 

  2. Harrison LE, Brennan MF, Newman E, Fortner JG, Picardo A, Blumgart LH, Fong Y (1997) Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 121(6):625–632

    Article  CAS  PubMed  Google Scholar 

  3. Shah SA, Bromberg R, Coates A, Rempel E, Simunovic M, Gallinger S (2007) Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg 205(5):676–683

    Article  PubMed  Google Scholar 

  4. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1,001 consecutive cases. Ann Surg 230(3):309–318; discussion 318–321

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Abad A, Figueras J, Valls C, Carrato A, Pardo F, Diaz-Rubio E, Aranda E (2007) Guidelines for the detection and treatment of liver metastases of colorectal cancer. Clin Transl Oncol 9(11):723–730

    Article  CAS  PubMed  Google Scholar 

  6. Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC (2006) Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 17(8):1235–1249; quiz 1250

    Article  PubMed  Google Scholar 

  7. Cobourn CS, Makowka L, Langer B, Taylor BR, Falk RE (1987) Examination of patient selection and outcome for hepatic resection for metastatic disease. Surg Gynecol Obstet 165(3):239–246

    CAS  PubMed  Google Scholar 

  8. Wolf RF, Goodnight JE, Krag DE, Schneider PD (1991) Results of resection and proposed guidelines for patient selection in instances of non-colorectal hepatic metastases. Surg Gynecol Obstet 173(6):454–460

    CAS  PubMed  Google Scholar 

  9. Knowles B, Bellamy CO, Oniscu A, Wigmore SJ (2010) Hepatic resection for metastatic endometrioid carcinoma. HPB (Oxford) 12(6):412–417

    Article  Google Scholar 

  10. Permuth-Wey J, Sellers TA (2009) Epidemiology of ovarian cancer. Methods Mol Biol 472:413–437

    Article  PubMed  Google Scholar 

  11. Tangjitgamol S, Levenback CF, Beller U, Kavanagh JJ (2004) Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol Cancer 14(3):399–422

    Article  CAS  PubMed  Google Scholar 

  12. Morgan RJ Jr, Alvarez RD, Armstrong DK, Boston B, Burger RA, Chen LM, Copeland L, Crispens MA, Gershenson D, Gray HJ, Grigsby PW, Hakam A, Havrilesky LJ, Johnston C, Lele S, Matulonis UA, O’Malley DM, Penson RT, Remmenga SW, Sabbatini P, Schilder RJ, Schink JC, Teng N, Werner TL, National Comprehensive Cancer Network (2011) Epithelial ovarian cancer. J Natl Compr Canc Netw 9(1):82–113

    PubMed  Google Scholar 

  13. Morch LS, Lokkegaard E, Andreasen AH, Kruger-Kjaer S, Lidegaard O (2009) Hormone therapy and ovarian cancer. JAMA 302(3):298–305

    Article  PubMed  Google Scholar 

  14. Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SA (2006) Hereditary ovarian cancer clinical study G. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 296(2):185–192

    Article  CAS  PubMed  Google Scholar 

  15. Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, Patras J, Mahony BS, Andersen MR (2007) Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 109(2):221–227

    Article  PubMed  Google Scholar 

  16. Nougaret S, Addley HC, Colombo PE, Fujii S, Al Sharif SS, Tirumani SH, Jardon K, Sala E, Reinhold C (2012) Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics 32(6):1775–1800; discussion 1800–1773

    Article  PubMed  Google Scholar 

  17. Zivanovic O, Eisenhauer EL, Zhou Q, Iasonos A, Sabbatini P, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS (2008) The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecol Oncol 108(2):287–292

    Article  PubMed  Google Scholar 

  18. Lim MC, Kang S, Lee KS, Han SS, Park SJ, Seo SS, Park SY (2009) The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer. Gynecol Oncol 112(1):28–34

    Article  PubMed  Google Scholar 

  19. Rose PG, Piver MS, Tsukada Y, Lau TS (1989) Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer 64(7):1508–1513

    Article  CAS  PubMed  Google Scholar 

  20. Stier EA, Barakat RR, Curtin JP, Brown CL, Jones WB, Hoskins WJ (1996) Laparotomy to complete staging of presumed early ovarian cancer. Obstet Gynecol 87(5 Pt 1):737–740

    Article  CAS  PubMed  Google Scholar 

  21. du Bois A, Quinn M, Thigpen T, Vermorken J, Avall-Lundqvist E, Bookman M, Bowtell D, Brady M, Casado A, Cervantes A, Eisenhauer E, Friedlaender M, Fujiwara K, Grenman S, Guastalla JP, Harper P, Hogberg T, Kaye S, Kitchener H, Kristensen G, Mannel R, Meier W, Miller B, Neijt JP, Oza A, Ozols R, Parmar M, Pecorelli S, Pfisterer J, Poveda A, Provencher D, Pujade-Lauraine E, Randall M, Rochon J, Rustin G, Sagae S, Stehman F, Stuart G, Trimble E, Vasey P, Vergote I, Verheijen R, Wagner U, Gynecologic Cancer Intergroup, Ago Ovar, Anzgog, Eortc, Geico, Gineco, Gog, Jgog, Mrc/Ncri, Ncic CTG, Nci US, Nsgo, Rtog, Sgctg, Igcs, Organizational team of the two prior International OCCC (2005) 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol 16(Suppl 8):viii7–viii12

    PubMed  Google Scholar 

  22. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, Jarnagin WR, DeMatteo RP, D’Angelica MI, Barakat RR, Chi DS (2006) The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol 103(3):1083–1090

    Article  PubMed  Google Scholar 

  23. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer 115(6):1234–1244

    Article  PubMed  Google Scholar 

  24. Steed H, Oza AM, Murphy J, Laframboise S, Lockwood G, DEP D, Sturgeon J, Rosen B (2006) A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer. Int J Gynecol Cancer 16(Suppl 1):47–53

    Article  PubMed  Google Scholar 

  25. Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P (2009) Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review. Gynecol Oncol 112(1):257–264

    Article  PubMed  Google Scholar 

  26. Vandenput I, Van Calster B, Capoen A, Leunen K, Berteloot P, Neven P, Moerman P, Vergote I, Amant F (2009) Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? Br J Cancer 101(2):244–249

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Tiersten AD, Liu PY, Smith HO, Wilczynski SP, Robinson WR 3rd, Markman M, Alberts DS (2009) Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009. Gynecol Oncol 112(3):444–449

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Meigs JV (1935) Ovarian tumors with endocrine significance. Ann Surg 102(5):834–848

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Griffiths CT (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42:101–104

    CAS  PubMed  Google Scholar 

  30. Wimberger P, Lehmann N, Kimmig R, Burges A, Meier W, Du Bois A, Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (2007) Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol 106(1):69–74

    Article  PubMed  Google Scholar 

  31. Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, Sonoda Y, Levine DA, Hensley M, Barakat RR (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103(2):559–564

    Article  CAS  PubMed  Google Scholar 

  32. Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P (2013) Interval debulking surgery for advanced epithelial ovarian cancer. Cochrane Database Syst Rev 2:CD006014

    Google Scholar 

  33. Eisenkop SM, Friedman RL, Spirtos NM (2000) The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 88(1):144–153

    Article  CAS  PubMed  Google Scholar 

  34. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics. CA Cancer J Clin 59(4):225–249

    Article  PubMed  Google Scholar 

  35. Averette HE, Donato DM (1990) Ovarian carcinoma. Advances in diagnosis, staging, and treatment. Cancer 65(3 Suppl):703–708

    Article  CAS  PubMed  Google Scholar 

  36. Wagner BJ, Buck JL, Seidman JD, McCabe KM (1994) From the archives of the AFIP. Ovarian epithelial neoplasms: radiologic-pathologic correlation. Radiographics 14(6):1351–1374; quiz 1375–1356

    Article  CAS  PubMed  Google Scholar 

  37. Kolev V, Pereira EB, Schwartz M, Sarpel U, Roayaie S, Labow D, Momeni M, Chuang L, Dottino P, Rahaman J, Zakashansky K (2014) The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer. Int J Gynecol Cancer 24(1):70–74

    Article  PubMed  Google Scholar 

  38. Niu GC, Shen CM, Cui W, Li Q (2012) Hepatic resection is safe for metachronous hepatic metastases from ovarian cancer. Cancer Biol Med 9(3):182–187

    PubMed Central  PubMed  Google Scholar 

  39. Pekmezci S, Saribeyoglu K, Aytac E, Arvas M, Demirkiran F, Ozguroglu M (2010) Surgery for isolated liver metastasis of ovarian cancer. Asian J Surg 33(2):83–88

    Article  PubMed  Google Scholar 

  40. Naik R, Nordin A, Cross PA, Hemming D, de Barros LA, Monaghan JM (2000) Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases. Gynecol Oncol 78(2):171–175

    Article  CAS  PubMed  Google Scholar 

  41. Yoon SS, Jarnagin WR, Fong Y, DeMatteo RP, Barakat RR, Blumgart LH, Chi DS (2003) Resection of recurrent ovarian or fallopian tube carcinoma involving the liver. Gynecol Oncol 91(2):383–388

    Article  PubMed  Google Scholar 

  42. Abood G, Bowen M, Potkul R, Aranha G, Shoup M (2008) Hepatic resection for recurrent metastatic ovarian cancer. Am J Surg 195(3):370–373; discussion 373

    Article  PubMed  Google Scholar 

  43. Chi DS, Fong Y, Venkatraman ES, Barakat RR (1997) Hepatic resection for metastatic gynecologic carcinomas. Gynecol Oncol 66(1):45–51

    Article  CAS  PubMed  Google Scholar 

  44. Prat J (2004) Prognostic parameters of endometrial carcinoma. Hum Pathol 35(6):649–662

    Article  PubMed  Google Scholar 

  45. Barlin JN, Wysham WZ, Ferda AM, Khoury-Collado F, Cassella DK, Alektiar KM, Hensley ML, Chi DS, Barakat RR, Abu-Rustum NR (2012) Location of disease in patients who die from endometrial cancer: a study of 414 patients from a single institution. Int J Gynecol Cancer 22(9):1527–1531

    PubMed  Google Scholar 

  46. Creasman WT, Kohler MF, Odicino F, Maisonneuve P, Boyle P (2004) Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol 95(3):593–596

    Article  PubMed  Google Scholar 

  47. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Elashoff RM (1983) Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 61(4):413–420

    CAS  PubMed  Google Scholar 

  48. Hoskins WJ, Rubin SC (1991) Surgery in the treatment of patients with advanced ovarian cancer. Semin Oncol 18(3):213–221

    CAS  PubMed  Google Scholar 

  49. Heyer H, Grunwald S, Kohler G, Ohlinger R (2007) Significance of laboratory studies for ruling out metastases in primary endometrial carcinoma. Anticancer Res 27(3B):1673–1677

    PubMed  Google Scholar 

  50. Yamazawa K, Hirashiki K, Usui H, Mitsuhashi A, Matsui H, Sekiya S (2005) Discordance between serum level and tissue immunohistochemical staining of CA125 in endometrioid adenocarcinoma of the uterine corpus. Int J Gynecol Pathol 24(3):254–259

    Article  PubMed  Google Scholar 

  51. Santala M, Talvensaari-Mattila A, Kauppila A (2003) Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer. Anticancer Res 23(3C):3097–3103

    CAS  PubMed  Google Scholar 

  52. Kurra V, Krajewski KM, Jagannathan J, Giardino A, Berlin S, Ramaiya N (2013) Typical and atypical metastatic sites of recurrent endometrial carcinoma. Cancer Imaging 13:113–122

    Article  PubMed Central  PubMed  Google Scholar 

  53. Grigsby PW, Perez CA, Kuten A, Simpson JR, Garcia DM, Camel HM, Kao MS, Galakatos AE (1992) Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys 22(5):905–911

    Article  CAS  PubMed  Google Scholar 

  54. Aalders JG, Abeler V, Kolstad P (1984) Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 17(1):85–103

    Article  CAS  PubMed  Google Scholar 

  55. Mundt AJ, McBride R, Rotmensch J, Waggoner SE, Yamada SD, Connell PP (2001) Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 50(5):1145–1153

    Article  CAS  PubMed  Google Scholar 

  56. Elliott P, Green D, Coates A, Krieger M, Russell P, Coppleson M, Solomon J, Tattersall M (1994) The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer 4(2):84–93

    Article  CAS  PubMed  Google Scholar 

  57. Sohaib SA, Houghton SL, Meroni R, Rockall AG, Blake P, Reznek RH (2007) Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol 62(1):28–34; discussion 35–26

    Article  CAS  PubMed  Google Scholar 

  58. Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, Benda J, Cella D (2009) Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 27(28):4649–4655

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Kim GE, Lee SW, Suh CO, Park TK, Kim JW, Park JT, Shim JU (1998) Hepatic metastases from carcinoma of the uterine cervix. Gynecol Oncol 70(1):56–60

    Article  CAS  PubMed  Google Scholar 

  60. Kaseki H, Yasui K, Niwa K, Mizuno K, Inoue T, Ota M (1992) Hepatic resection for metastatic squamous cell carcinoma from the uterine cervix. Gynecol Oncol 44(3):284–287

    Article  CAS  PubMed  Google Scholar 

  61. Papadia A, Moya Y, Rodgers SE, Lucci JA 3rd, Diaz JP (2011) Surgical resection of recurrent upper abdominal cervical cancer: a case report and review of the literature. Gynecol Oncol Case Rep 1(1):8–9

    Article  PubMed Central  PubMed  Google Scholar 

  62. Foster JH (1978) Survival after liver resection for secondary tumors. Am J Surg 135(3):389–394

    Article  CAS  PubMed  Google Scholar 

  63. La Fianza A, Alberici E, Biasina AM, Preda L, Tateo S, Campani R (1999) Spontaneous hemorrhage of a liver metastasis from squamous cell cervical carcinoma: case report and review of the literature. Tumori 85(4):290–293

    PubMed  Google Scholar 

  64. FIGO Cancer Committee staging announcement (1968) Gynecol Oncol 25:383–385

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, UK

    Anya Adair & Stephen J. Wigmore

Authors
  1. Anya Adair
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen J. Wigmore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen J. Wigmore .

Editor information

Editors and Affiliations

  1. Department of Surgical Sciences Organ Transplantation and Advanced Technologies, University of Catania, Cannizzaro Hospital, Catania, Catania, Italy

    Isidoro Di Carlo

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Adair, A., Wigmore, S.J. (2015). Liver Metastases from Ovarian and Uterus Cancer. In: Di Carlo, I. (eds) Noncolorectal, Nonneuroendocrine Liver Metastases. Springer, Cham. https://doi.org/10.1007/978-3-319-09293-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09293-5_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09292-8

  • Online ISBN: 978-3-319-09293-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation